Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Helix raises C$16.9 million

Helix (TSX:HBP; FSE:HBP) raised C$16.9 million ($16.6 million) through

Read the full 95 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE